Henry Schein, Inc. (HSIC) Receives Average Recommendation of “Hold” from Brokerages

Henry Schein, Inc. (NASDAQ:HSIC) has been given an average recommendation of “Hold” by the eighteen brokerages that are covering the company, Marketbeat reports. Two research analysts have rated the stock with a sell recommendation, seven have given a hold recommendation and eight have issued a buy recommendation on the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $84.23.

Several analysts recently commented on the stock. Stephens assumed coverage on shares of Henry Schein in a research report on Tuesday, November 28th. They set an “equal weight” rating and a $76.00 price target on the stock. TheStreet lowered shares of Henry Schein from a “b” rating to a “c+” rating in a research report on Monday, November 6th. Jefferies Group dropped their price target on shares of Henry Schein from $89.00 to $74.00 and set a “hold” rating on the stock in a research report on Tuesday, November 7th. Royal Bank of Canada dropped their price target on shares of Henry Schein from $91.00 to $82.00 and set a “sector perform” rating on the stock in a research report on Tuesday, November 7th. Finally, Stifel Nicolaus dropped their price target on shares of Henry Schein from $89.00 to $77.00 and set a “hold” rating on the stock in a research report on Tuesday, November 7th.

Shares of Henry Schein (NASDAQ:HSIC) opened at $74.62 on Friday. The firm has a market cap of $11,710.00, a price-to-earnings ratio of 21.50, a PEG ratio of 1.94 and a beta of 0.99. Henry Schein has a 52 week low of $65.28 and a 52 week high of $93.50. The company has a quick ratio of 0.86, a current ratio of 1.55 and a debt-to-equity ratio of 0.30.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Monday, November 6th. The company reported $0.87 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.90 by ($0.03). The business had revenue of $3.16 billion during the quarter, compared to analyst estimates of $3.05 billion. Henry Schein had a return on equity of 19.71% and a net margin of 4.52%. The firm’s revenue was up 10.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.84 EPS. research analysts forecast that Henry Schein will post 3.6 EPS for the current fiscal year.

In other Henry Schein news, Director Barry J. Alperin sold 5,796 shares of the stock in a transaction on Friday, December 1st. The shares were sold at an average price of $70.76, for a total transaction of $410,124.96. Following the transaction, the director now directly owns 48,172 shares of the company’s stock, valued at $3,408,650.72. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 1.19% of the company’s stock.

A number of institutional investors and hedge funds have recently bought and sold shares of HSIC. Alecta Pensionsforsakring Omsesidigt lifted its holdings in Henry Schein by 112.0% during the third quarter. Alecta Pensionsforsakring Omsesidigt now owns 5,313,980 shares of the company’s stock valued at $435,693,000 after purchasing an additional 2,806,990 shares in the last quarter. Mackenzie Financial Corp lifted its holdings in Henry Schein by 106.0% during the third quarter. Mackenzie Financial Corp now owns 3,938,233 shares of the company’s stock valued at $322,896,000 after purchasing an additional 2,026,867 shares in the last quarter. Janus Henderson Group PLC lifted its holdings in Henry Schein by 92.1% during the third quarter. Janus Henderson Group PLC now owns 2,814,636 shares of the company’s stock valued at $230,777,000 after purchasing an additional 1,349,333 shares in the last quarter. Atlanta Capital Management Co. L L C lifted its holdings in Henry Schein by 99.4% during the third quarter. Atlanta Capital Management Co. L L C now owns 2,493,054 shares of the company’s stock valued at $204,405,000 after purchasing an additional 1,242,849 shares in the last quarter. Finally, Neuberger Berman Group LLC lifted its holdings in Henry Schein by 95.9% during the third quarter. Neuberger Berman Group LLC now owns 2,475,058 shares of the company’s stock valued at $202,930,000 after purchasing an additional 1,211,743 shares in the last quarter. 91.70% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: This report was originally reported by American Banking News and is the property of of American Banking News. If you are viewing this report on another publication, it was illegally stolen and republished in violation of international copyright & trademark law. The correct version of this report can be viewed at https://www.americanbankingnews.com/2018/01/19/henry-schein-inc-hsic-receives-average-recommendation-of-hold-from-brokerages.html.

Henry Schein Company Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Analyst Recommendations for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply